Published in Hepatitis Weekly, October 16th, 1995
In most patients, the finding is reversible with the disappearance of antibodies after therapy is discontinued, added Carlo Carella, Second University, Naples, Italy, and colleagues.
Carella et al. explored the occurrence of autoimmune thyroid disease (AITD) or for the worsening of thyroid pre-existing abnormalities in patients with chronic viral hepatitis C both during and following therapy with IFN-(alpha)-2a ("Longitudinal Study of Antibodies against Thyroid in Patients Undergoing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.